Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Wuerstlein

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Drugs|October 16, 2013
Optimal sequencing of anti-HER2 therapy throughout the continuum of HER2-positive breast cancer: evidence and clinical considerationsNadia Harbeck, Rachel Wuerstlein
Breast Care (Basel, Switzerland)|May 7, 2011
Tumor-Specific Systemic Treatment in Advanced Breast Cancer - How Long does it Make Sense?Rachel Wuerstlein, Ingo Bauerfeind
Nature Reviews. Clinical Oncology|January 16, 2019
Truly personalized therapy - an end to the era of one size fits allNadia Harbeck, Rachel Wuerstlein
Reviews on Recent Clinical Trials|February 7, 2017
Neoadjuvant Therapy for HER2-positive Breast CancerRachel Wuerstlein, Nadia Harbeck
Breast Care (Basel, Switzerland)|March 31, 2022
Expert Discussion: Highlights from ABC6: Bridging the Gap and Insights in This First Virtual ABC Conference and from 10 Years ABC ConsensusRachel Wuerstlein, Fatima Cardoso, Renate Haidinger
Geburtshilfe Und Frauenheilkunde|September 30, 2017
How Do Patients Experience Individualized Medicine? A Qualitative Interview-based Study of Gene Expression Analyses in the Treatment of Breast CancerSebastian Schleidgen, Sandra Thiersch, Rachel Wuerstlein, et al.
Expert Opinion on Drug Safety|January 18, 2018
The safety of palbociclib for the treatment of advanced breast cancerTom Degenhardt, Rachel Wuerstlein, Tanja Eggersmann, et al.
Psycho-Oncology|December 5, 2018
Recover your smile: Effects of a beauty care intervention on depressive symptoms, quality of life, and self-esteem in patients with early breast cancerAnna Richard, Nadia Harbeck, Rachel Wuerstlein, et al.
Breast Care (Basel, Switzerland)|March 17, 2012
COMBATing Breast Cancer Conference 2011 -Stories of Success and FailureJulian Puppe, Rachel Wuerstlein, Stefan Kraemer, et al.
Cancer Treatment Reviews|October 22, 2013
Molecular and protein markers for clinical decision making in breast cancer: today and tomorrowNadia Harbeck, Karl Sotlar, Rachel Wuerstlein, et al.
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Drugs|October 16, 2013
Optimal sequencing of anti-HER2 therapy throughout the continuum of HER2-positive breast cancer: evidence and clinical considerationsNadia Harbeck, Rachel Wuerstlein
Breast Care (Basel, Switzerland)|May 7, 2011
Tumor-Specific Systemic Treatment in Advanced Breast Cancer - How Long does it Make Sense?Rachel Wuerstlein, Ingo Bauerfeind
Nature Reviews. Clinical Oncology|January 16, 2019
Truly personalized therapy - an end to the era of one size fits allNadia Harbeck, Rachel Wuerstlein
Reviews on Recent Clinical Trials|February 7, 2017
Neoadjuvant Therapy for HER2-positive Breast CancerRachel Wuerstlein, Nadia Harbeck
Breast Care (Basel, Switzerland)|March 31, 2022
Expert Discussion: Highlights from ABC6: Bridging the Gap and Insights in This First Virtual ABC Conference and from 10 Years ABC ConsensusRachel Wuerstlein, Fatima Cardoso, Renate Haidinger
Geburtshilfe Und Frauenheilkunde|September 30, 2017
How Do Patients Experience Individualized Medicine? A Qualitative Interview-based Study of Gene Expression Analyses in the Treatment of Breast CancerSebastian Schleidgen, Sandra Thiersch, Rachel Wuerstlein, et al.
Expert Opinion on Drug Safety|January 18, 2018
The safety of palbociclib for the treatment of advanced breast cancerTom Degenhardt, Rachel Wuerstlein, Tanja Eggersmann, et al.
Psycho-Oncology|December 5, 2018
Recover your smile: Effects of a beauty care intervention on depressive symptoms, quality of life, and self-esteem in patients with early breast cancerAnna Richard, Nadia Harbeck, Rachel Wuerstlein, et al.
Breast Care (Basel, Switzerland)|March 17, 2012
COMBATing Breast Cancer Conference 2011 -Stories of Success and FailureJulian Puppe, Rachel Wuerstlein, Stefan Kraemer, et al.
Cancer Treatment Reviews|October 22, 2013
Molecular and protein markers for clinical decision making in breast cancer: today and tomorrowNadia Harbeck, Karl Sotlar, Rachel Wuerstlein, et al.
Pageof 15